1. Cannabis and schizophrenia: characterisation of a risk factor in a sample of Moroccan patients hospitalised for psychosis
- Author
-
El Hassan Ouanouche, Hicham Elmostafi, Naoufal Amarat, Ouahid Wafaa, Tamouza Ryad, Aboubaker El Hessni, and Abdelhalem Mesfioui
- Subjects
Addiction ,Cannabis users ,Schizophrenia ,Disorder and predictivity ,Psychiatry ,RC435-571 - Abstract
Abstract Background In addition to the biological plausibility widely described through a very large number of studies, the causal link between cannabis uses and schizophrenia disorders has become illicit internationally and given the scarcity of similar studies in Morocco. Our study consists of a prospective descriptive study in the psychiatric department of the Moulay ben Abdallah Hospital in Essaouira. The sample consisted of 95 patients diagnosed with schizophrenia according to the DSM5 criteria. The diagnostic assessment included the Positive and Negative Syndrome Scale to assess the severity of positive and negative symptoms of schizophrenia as well as the patient’s general psychopathology, the Clinician-Rated Dimensions of Psychosis Symptom Severity to assess the symptom severity of the psychotic dimensions according, and the Cannabis Abuse Screening Test to assess the extent of cannabis use. Results The mean age of the patients recruited in the study was 33.7 ± 9.37 years with a clear male predominance (p
- Published
- 2022
- Full Text
- View/download PDF